.png)
When you benchmark your practice against industry standards, you stop guessing and start managing. Most independent practices track revenue and expenses, maybe days in A/R, and call it a day. The numbers that actually predict financial trouble — denial rate trends, aging receivables, charge submission speed — go unmonitored until something breaks. For dermatology practices in particular, where modifier complexity and multi-procedure visits create more places for revenue to slip, the gap between what you bill and what you collect can widen quietly for months before anyone notices.
The cost of that blind spot is real. Practices lose up to 20% of potential income from billing process gaps, according to industry estimates. And net revenue losses from claim denials alone grew 25% year over year in 2025, per Kodiak Solutions' March 2026 analysis. The practices catching these problems early are the ones measuring consistently — and measuring the right things.
These seven metrics cover the full revenue cycle from claim creation to final collection. Each one tells you something different about where money enters your system, where it slows down, and where it disappears. If you're newer to RCM metrics, you might start with the 4 metrics dermatology practices monitor and expand from there.
What it measures: The percentage of allowed charges your practice actually collects. This is the single best indicator of overall revenue cycle performance.
Where you should be:
For dermatology practices, the bar is higher. The target range is 96-99% because specialty coding complexity — particularly around modifiers -25 and -59 — means there's more room for revenue to slip through when coding isn't precise. Mohs-heavy practices should expect 97% or above. Clarity RCM's clients average 98%. For a deeper look at how NCR works in dermatology specifically, see our breakdown of net collection rate benchmarks for dermatology.
Why it matters: A practice collecting 91% instead of 97% on $3 million in allowed charges is leaving $180,000 on the table annually. That gap usually lives in modifier errors, unworked denials, and fee schedule mismatches — fixable problems, once you can see them.
What it measures: The average number of days it takes to collect payment after a claim is submitted.
Where you should be:
Dermatology practices should target under 35 days. Clarity RCM's average across 200+ practices is 23 days.
Why it matters: Every extra day your money sits in A/R is a day you're financing your payers' cash flow instead of your own. Practices with high A/R days typically have follow-up gaps — claims that aged past 30 days without anyone touching them. The longer a claim sits, the harder it is to collect. After 90 days, the recovery rate drops sharply.
What it measures: The percentage of claims that are accepted by the payer on the first submission without rejections or edits.
Where you should be:
Clarity RCM maintains a 98%+ first-pass clean claim rate.
Why it matters: Every claim that bounces costs you twice — the delay in payment and the labor to rework it. Reworking a denied claim costs between $25 and $118 depending on complexity. In dermatology, common rejection triggers include incorrect modifier use on same-day E/M and procedure visits, medical necessity documentation gaps for Mohs and pathology, and missing biopsy/excision anatomical details.
What it measures: The percentage of claims denied by payers on initial submission.
Where you should be:
The trend is heading the wrong direction. Initial claim denials hit 11.8% in 2024, and 41% of providers now report denial rates above 10%, up from 30% three years ago. Net revenue losses from final denials and bad debt grew 25% in 2025 according to Kodiak Solutions.
Why it matters: 65% of denied claims are never resubmitted. Every denial your team doesn't work is revenue that simply vanishes. For a practice with $5 million in annual charges and a 10% denial rate, that's up to $325,000 in claims that never get appealed.
What it measures: The percentage of your total accounts receivable that has been outstanding for more than 90 days.
Where you should be:
Why it matters: This metric is your early warning system. When claims age past 90 days, collection probability drops and write-off risk climbs. A rising A/R over 90 days percentage — even if your overall A/R days look fine — often signals that your team is prioritizing new claims while older ones go unworked. Track the trend month over month. A steady increase usually means newer claims are getting worked while older ones age out — follow-up queues get sorted by submission date, not by dollar value, so the highest-balance aged claims sit at the bottom of the list until they're past the filing deadline.
What it measures: The number of days between a patient encounter and when the claim is submitted to the payer.
Where you should be:
This is one of the least-tracked metrics in practice management, but it matters more than most realize. MGMA DataDive tracks it as "charge posting lag," but few practices monitor it actively. Clarity RCM submits charges within 24-48 hours of the encounter.
Why it matters: Every day of charge lag is a day your A/R clock hasn't even started. If your average charge lag is 5 days and your A/R is 35 days, your actual time-to-payment is 40 days. Reducing charge lag is often the fastest way to improve cash flow because it doesn't require payer negotiation or process overhaul — just tighter submission workflows.
What it measures: How much you spend to collect every dollar of net patient revenue, including billing staff, technology, outsourced services, and follow-up costs.
Where you should be:
Why it matters: Cost to collect puts your other metrics in context. A 97% NCR means less if you're spending 5% to achieve it. This metric is especially relevant when evaluating whether to keep billing in-house versus outsourcing. Many practices discover their true cost to collect is higher than they think once they account for staff benefits, training, software licenses, clearinghouse fees, and management time.
Knowing the targets is only useful if you have a reliable process for measuring against them. Here's a practical framework that walks through the steps of revenue cycle management from a measurement perspective.
Start with your practice management system and clearinghouse reports. For each of the seven metrics above, document your current 90-day average. Don't use a single month — billing is seasonal, and a one-month snapshot can be misleading. If you can pull 12 months of data, even better, because you'll see trends in addition to point-in-time values.
Generic benchmarks are a starting point, not a destination. A solo dermatology practice in rural Texas has different economics than a 15-provider multi-site group in Manhattan. Use MGMA DataDive if available (it segments by specialty, practice size, and region), or work with your billing partner to identify relevant peer comparisons. At minimum, filter by specialty — general healthcare averages will understate what a dermatology practice should expect.
You'll likely find gaps across multiple metrics. Focus on the ones with the largest revenue impact first. NCR and denial rate almost always top the list because small percentage improvements translate to meaningful dollar amounts. A 2-point improvement in NCR on a $4 million practice is $80,000 in annual recovered revenue.
A below-benchmark metric is a symptom. The question is what's driving it. High denial rates in dermatology, for instance, often trace back to modifier -25 documentation, where the E/M service isn't sufficiently distinguished from the procedure in the clinical note. High A/R days might mean payer follow-up happens at 45 days instead of 21. Look at the workflow, not just the number.
Set realistic improvement targets — closing 50% of the gap to benchmark within six months is aggressive but achievable for most practices. Review monthly, not quarterly. Quarterly reviews catch problems three months too late.
One of the most frequent missteps is comparing against the wrong peer group. A dermatology practice measuring itself against all-specialty MGMA averages will look fine at a 93% NCR, but against derm-specific benchmarks, that same 93% signals a real collection problem. The specificity of your comparison set matters as much as the metrics themselves — a practice that benchmarks against generalists will consistently set the bar too low and miss fixable gaps.
Another common error is trying to track too many metrics at once. Seven is already a lot. Practices that spread their attention across a dozen KPIs tend to improve none of them. Pick two or three to focus on first, build the reporting habit around those, and expand your dashboard once the first batch is on track.
There's also the question of which collection metric you're actually using. Gross collection rate — total collected divided by total billed — is inflated by your fee schedule markup and tells you almost nothing useful. NCR, which divides collected amounts by allowed amounts, tells you what you're actually capturing of what payers agreed to pay. Practices that report a "95% collection rate" using the gross formula often discover their NCR is closer to 88% once they calculate it correctly.
Benchmarking once and moving on is another trap. Revenue cycle performance shifts with payer policy changes, staff turnover, coding updates, and patient volume fluctuations. A benchmark that looked fine in January can be off track by June if a major payer changed its modifier requirements or your lead coder left. Monthly tracking is the minimum cadence that catches these shifts while they're still correctable.
Finally, most practices have no idea how long it takes from encounter to claim submission. Charge lag is the least-tracked metric on this list, and it's one of the easiest to fix. Every extra day of lag pushes out your entire revenue timeline, and unlike payer follow-up, reducing it requires only internal process changes.
Consider a 5-provider dermatology practice in the Southeast doing $6 million in annual charges — the kind of practice where dermatology deserves its own RCM approach because of the billing complexity that comes with Mohs, pathology, and multi-procedure visits. Their quarterly benchmark review reveals:
The story these numbers tell: claims are going out with errors (88% clean claim rate), which causes denials (9%), which slows down payment (38 days A/R), which leads to aging receivables (18% over 90 days), which depresses collections (94% NCR). The root cause likely sits in claim preparation and coding quality — fix that, and the downstream metrics should follow.
The practice prioritizes clean claim rate and denial rate as their focus areas for the next quarter. They audit their top 10 denial reasons, find that modifier -25 and -59 issues account for 40% of denials, and implement a pre-submission scrub focusing on same-day E/M and procedure claims. Within three months, their clean claim rate moves to 93% and denial rate drops to 6%.
A 3-point denial rate improvement on $6 million in charges recovers roughly $180,000 in claims that now get paid on the first pass instead of sitting in a denial queue or never getting resubmitted at all.
Benchmarking works because it replaces assumptions with data. Most practice leaders have a general sense of how their revenue cycle is performing, but "general sense" doesn't catch a creeping denial rate or a charge lag that adds a hidden week to your A/R. The seven metrics in this article give you a framework to measure what matters, compare it against real industry standards, and prioritize where to focus your team's effort.
You don't need to fix everything at once. Start with the two metrics that have the biggest dollar gap, understand what's driving them, and track your progress monthly. The practices that do this consistently are the ones that collect more of what they earn.
Q: How often should I benchmark my practice against industry standards?
A: Monthly is ideal for your core metrics (NCR, A/R days, denial rate). At minimum, benchmark quarterly. Annual benchmarking is too infrequent to catch trends before they become problems. Set up automated reporting in your practice management system so the data is waiting for you each month.
Q: Where can I find reliable benchmarks for my specialty?
A: MGMA DataDive is the gold standard for specialty-specific benchmarks, though it requires a paid subscription. HFMA publishes free resources on key RCM metrics including their MAP Keys framework covering 29 industry-standard KPIs. Your billing partner or RCM vendor should also be able to provide relevant peer benchmarks.
Q: What's the most important metric for a dermatology practice to track?
A: Net collection rate, because it reflects the cumulative impact of everything else — coding accuracy, denial management, follow-up effectiveness, and fee schedule optimization. If your NCR is at 96%+, the rest of your revenue cycle is probably working well. If it's below 94%, something upstream needs attention.
Q: Should I use gross collection rate or net collection rate?
A: Always net collection rate. Gross collection rate (collected divided by billed charges) is distorted by your fee schedule, which most practices set above payer-allowed amounts. NCR measures what you collected against what you were actually eligible to collect. It's the only metric that gives you an honest picture of collection performance.
Q: How do I calculate my practice's cost to collect?
A: Add up all revenue cycle costs: billing staff salaries and benefits, practice management and clearinghouse software, outsourced billing fees, collection agency costs, postage for patient statements, and management time spent on billing oversight. Divide that total by your net patient revenue. If the result is above 4%, there's likely room for improvement.
Q: What's the difference between charge lag and days in A/R?
A: Charge lag measures the gap between the patient encounter and when the claim goes out the door. Days in A/R measures the gap between claim submission and payment. They're sequential. A practice with 4 days of charge lag and 35 days in A/R is actually waiting 39 days from service to payment. Reducing charge lag is often the quickest cash flow win because it requires internal process changes rather than payer negotiations.
Q: Can a small practice (1-3 providers) realistically hit these benchmarks?
A: Yes, but the path is different. Small practices often lack dedicated billing staff, which makes consistent follow-up harder. Outsourcing to a specialty-focused billing partner can help smaller practices reach benchmarks that would require significant internal investment to achieve on their own. The benchmarks themselves don't change based on practice size — a 95% NCR is a 95% NCR whether you have 2 providers or 20.
Q: My denial rate looks good, but my NCR is still below benchmark. Why?
A: A few common causes: underpayments that aren't being caught and appealed, fee schedules that haven't been updated to reflect current payer contracts, patient balances that aren't being collected, or a cosmetic/medical revenue mix where the medical side is strong but cosmetic collections are lagging. NCR is a composite metric, and denial rate is just one input. Review each revenue stream separately to find where the gap lives.
Benchmarking is most valuable when you have someone to help you interpret the results and build a plan around them. Clarity RCM works exclusively with independent dermatology practices, managing $1.13 billion in annual charges across 1,246+ providers in 42 states. Our clients average a 98% net collection rate and 23 days in A/R.
